These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20521155)

  • 1. Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method.
    Fry NK; Duncan J; Vaghji L; George RC; Harrison TG
    Eur J Clin Microbiol Infect Dis; 2010 Sep; 29(9):1183-5. PubMed ID: 20521155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
    Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
    Cent Eur J Public Health; 2017 Dec; 25(4):282-286. PubMed ID: 29346850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility testing of Finnish Bordetella pertussis isolates collected during 2006-2017.
    Lönnqvist E; Barkoff AM; Mertsola J; He Q
    J Glob Antimicrob Resist; 2018 Sep; 14():12-16. PubMed ID: 29486357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient.
    Yao SM; Liaw GJ; Chen YY; Yen MH; Chen YH; Mu JJ; Chiang CS
    J Med Microbiol; 2008 Dec; 57(Pt 12):1577-1580. PubMed ID: 19018032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents.
    Hill BC; Baker CN; Tenover FC
    J Clin Microbiol; 2000 Mar; 38(3):1151-5. PubMed ID: 10699011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United States.
    Korgenski EK; Daly JA
    J Clin Microbiol; 1997 Nov; 35(11):2989-91. PubMed ID: 9350776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).
    Hoppe JE; Bryskier A
    Antimicrob Agents Chemother; 1998 Apr; 42(4):965-6. PubMed ID: 9559823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China.
    Hua CZ; Wang HJ; Zhang Z; Tao XF; Li JP; Mi YM; Tang LF; Chen ZM
    J Glob Antimicrob Resist; 2019 Sep; 18():47-51. PubMed ID: 30710647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Susceptibility to macrolide antibiotics of Bordetella pertussis and Bordetella parapertussis strains isolated from whooping cough patients in 1968 and in 1997-99].
    Chodorowska M; Kuklińska D; Tyski S
    Med Dosw Mikrobiol; 2001; 53(1):39-43. PubMed ID: 11757403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program.
    Gordon KA; Fusco J; Biedenbach DJ; Pfaller MA; Jones RN
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3599-600. PubMed ID: 11709347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum inhibitory concentrations of erythromycin and other antibiotics for Czech strains of Bordetella pertussis.
    Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
    Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):12-5. PubMed ID: 25872990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance.
    Wilson KE; Cassiday PK; Popovic T; Sanden GN
    J Clin Microbiol; 2002 Aug; 40(8):2942-4. PubMed ID: 12149356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The First Report of Macrolide-Resistant Bordetella pertussis Isolation in Japan.
    Yamaguchi T; Kawasaki Y; Katsukawa C; Kawahara R; Kawatsu K
    Jpn J Infect Dis; 2020 Sep; 73(5):361-362. PubMed ID: 32350216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis.
    Hoppe JE; Eichhorn A
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):653-4. PubMed ID: 2550234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of antibiotic sensitivity and resistance genes of Bordetella pertussis in Chinese children.
    Lin X; Zou J; Yao K; Li L; Zhong L
    Medicine (Baltimore); 2021 Jan; 100(2):e24090. PubMed ID: 33466172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of erythromycin-resistant Bordetella pertussis in Xi'an, China.
    Wang Z; Cui Z; Li Y; Hou T; Liu X; Xi Y; Liu Y; Li H; He Q
    Clin Microbiol Infect; 2014 Nov; 20(11):O825-30. PubMed ID: 24816168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Nov; 43(44):807-10. PubMed ID: 7968996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where macrolide resistance is prevalent.
    Li Y; Liu X; Zhang B; He Q; Wang Z
    APMIS; 2015 Apr; 123(4):361-3. PubMed ID: 25703275
    [No Abstract]   [Full Text] [Related]  

  • 19. High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.
    Li L; Deng J; Ma X; Zhou K; Meng Q; Yuan L; Shi W; Wang Q; Li Y; Yao K
    Emerg Infect Dis; 2019 Dec; 25(12):2205-2214. PubMed ID: 31742507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin.
    Aoyama T; Sunakawa K; Iwata S; Takeuchi Y; Fujii R
    J Pediatr; 1996 Nov; 129(5):761-4. PubMed ID: 8917247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.